We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Erie Indemnity
ERIE
$11.7B
| $660K | 0.01% |
3,139
+1,524
| +94% | +$320K |
|
|
NVTA
1227
DELISTED
Invitae Corporation
NVTA
| $659K | 0.01% |
15,192
-34,547
| -69% | -$1.18M |
|
|
HMHC
1228
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $656K | 0.01% |
379,339
+258,680
| +214% | +$578K |
|
1229
CALL
Johnson & Johnson
JNJ
$635B
| $655K | 0.01% |
4,400
+600
| +16% | +$88.8K |
|
|
1230
PUT
Johnson & Johnson
JNJ
$635B
| $655K | 0.01% |
4,400
+600
| +16% | +$88.8K |
|
|
TGI
1231
DELISTED
Triumph Group
TGI
| $655K | 0.01% |
+100,572
| New | +$747K |
|
1232
3D Systems Corp
DDD
$420M
| $649K | 0.01% |
+132,093
| New | +$783K |
|
1233
Huron Consulting
HURN
$1.82B
| $649K | 0.01% |
16,489
-2,201
| -12% | -$95.9K |
|
|
BDSI
1234
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $649K | 0.01% |
173,908
+30,260
| +21% | +$129K |
|
1235
Titan Machinery
TITN
$466M
| $648K | 0.01% |
48,954
+36,349
| +288% | +$442K |
|
|
HR
1236
DELISTED
Healthcare Realty Trust Incorporated
HR
| $648K | 0.01% |
21,526
-37,975
| -64% | -$1.09M |
|
1237
Yext
YEXT
$501M
| $647K | 0.01% |
42,606
-747
| -2% | -$12.6K |
|
|
SGI
1238
Somnigroup International
SGI
$15.1B
| $644K | 0.01% |
28,896
-109,164
| -79% | -$2.26M |
|
1239
Cboe Global Markets
CBOE
$29.8B
| $643K | 0.01% |
7,324
-41,649
| -85% | -$3.75M |
|
|
HOUS
1240
DELISTED
Anywhere Real Estate
HOUS
| $643K | 0.01% |
68,149
+28,615
| +72% | +$275K |
|
1241
Cincinnati Financial
CINF
$28.3B
| $642K | 0.01% |
8,237
-11,287
| -58% | -$874K |
|
1242
Turning Point Brands
TPB
$1.47B
| $642K | 0.01% |
+23,005
| New | +$676K |
|
1243
Deluxe
DLX
$1.19B
| $640K | 0.01% |
24,886
-589
| -2% | -$15.2K |
|
1244
KALA BIO
KALA
$11.8M
| $639K | 0.01% |
34
-42
| -55% | -$965K |
|
1245
PTC Therapeutics
PTCT
$6.37B
| $638K | 0.01% |
13,638
+8,109
| +147% | +$399K |
|
|
SCS
1246
DELISTED
Steelcase
SCS
| $636K | 0.01% |
+62,885
| New | +$676K |
|
1247
Amneal Pharmaceuticals
AMRX
$5.72B
| $635K | 0.01% |
163,757
+152,027
| +1,296% | +$650K |
|
|
ENV
1248
DELISTED
ENVESTNET, INC.
ENV
| $634K | 0.01% |
8,213
-23,878
| -74% | -$1.91M |
|
1249
ONE Gas
OGS
$5.05B
| $633K | 0.01% |
9,170
-48,229
| -84% | -$3.55M |
|
1250
Evolent Health
EVH
$475M
| $632K | 0.01% |
+50,903
| New | +$599K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.